<DOC>
	<DOCNO>NCT00488683</DOCNO>
	<brief_summary>This study aim ass whether frequency meningococcal serogroup A , C , W-135 Y specific memory B Cells , measure 1 month primary vaccination series Novartis MenACWY vaccine , predict specific serum bactericidal activity use human complement ( hSBA ) ( respectively ) serogroup A , C , W-135 Y 12 month age</brief_summary>
	<brief_title>B Cell Response Primary Booster Course Novartis Meningococcal ACWY Conjugate Vaccine Healthy Infants</brief_title>
	<detailed_description />
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects eligible enrol study : healthy infant age 2 month ( 56 83 day old , inclusive ) ; available visit schedule study ; mother available blood draw Visit 1 ; good health determine clinical judgement investigator ; whose parent give write informed consent infant enrol study . The infant 's parent must willing infant receive full primary immunization course . Subjects eligible study : whose parent give unwilling unable give write informed consent child 's participation study know hypersensitivity vaccine contain within routine immunization schedule unacceptable concurrent illness condition e.g . : 1. severe acute chronic illness ; present suspect serious disease metabolic , cardiac autoimmune disease insulin dependent diabetes serious disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease ; 2. genetic anomaly , e.g . Down 's syndrome ; 3. immunodeficiency , include use systemic corticosteroid ; 4. born less 36 week gestation ; 5. weigh less 2.5 kg birth ; 6. previous clinical bacteriological diagnosis meningitis , history household contact intimate exposure individual culture prove Neisseria meningitidis disease ; 7. know bleeding diathesis , condition associate prolonged bleeding time ; receive prohibit prior concomitant medication e.g . : 1. immunization within 30 day prior enrollment , exception BCG hepatitis B ; 2. immunoglobulin ; 3. blood product ; participate clinical trial either currently previous month ; unable adhere protocol , include plan move area ; Other : Had condition , opinion investigator , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>83 Days</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Meningococcal disease</keyword>
	<keyword>Prevention</keyword>
	<keyword>Vaccination</keyword>
</DOC>